Quantcast

Synovial Sarcoma - Online Support Group

Sunitinib (Sutent) Plus Nivolumab (Opdivo)


#1

Here is a new European clinical trial testing the combination of Sunitinib (multi-targeted RTK inhibitor) with Nivolumab (anti-PD1):